Long
ENDP - 26 year all time low
ENDO has 110B assets, $1.4B cash, 33B sales. In Q1 2022, revenue was $654M alone. It’s trading at a severely undervalued market cap of $141M.
This big pharma company also owns Plan B pill, one of two approved. POTUS has been tweeting about increasing supply to Plan B contraceptives.
ENDO just won an 8 year opioid lawsuit case Friday, July 1st.
Current DCF fair value is $6.59. Likely to be upgraded higher after debt restructuring and potential Plan B deals.
Their pipeline includes 50+ other OTC medications.
This big pharma company also owns Plan B pill, one of two approved. POTUS has been tweeting about increasing supply to Plan B contraceptives.
ENDO just won an 8 year opioid lawsuit case Friday, July 1st.
Current DCF fair value is $6.59. Likely to be upgraded higher after debt restructuring and potential Plan B deals.
Their pipeline includes 50+ other OTC medications.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.